President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

January, the Biden administration released its proposed Medicare Advantage rates in 2026. These are the rates that the ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

An early move by the president has raised questions about what direction his second-term policy on drug costs will take.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Robert F. Kennedy, Jr. casts himself as “anti-establishment,” but he doesn’t object to the cruel profit-driven healthcare ...